Earnings History Data for Nutriband Inc. (NTRB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Nutriband Inc.

Nutriband Inc. is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. The company is engaged in developing to provide clinicians and patients with an abuse deterrent transdermal fentanyl product for use in managing chronic pain requiring opioid therapy. Nutriband Inc. is based in Orlando, United States.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
05-12-2022	PM	NTRB	Nutriband	31.00	-0.14	-0.07	0.00	Nutriband reports Q3 results [12/5/2022 9:15 AM]	3.90	-0.06 (-1.52%)	3.87	-0.03 (-0.83%)	2.41 - 10.44	12,543	10,000	397
Nutriband reports Q3 results [12/5/2022 9:15 AM] Nutriband Inc to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022 [Dec-02-22 07:00AM] Nutriband Receives Notice of Issuance from the Canadian Intellectual Property Office for its AVERSA(TM) Abuse Deterrent Transdermal Technology Patent [Dec-01-22 07:00AM] Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3 [Dec-05-22 07:00AM]
14-12-2021	AH	NTRB	Nutriband	43.00	-0.27	-0.04	0.00		5.06	-0.06 (-1.17%)	0.0	0.0 (0.00%)	1.00 - 32.00	7,092	30,000	0
Nutriband Inc. Receives cGMP Certification for Manufacturing Subsidiary [Dec-13-21 07:30AM]